He previously served as CDER Deputy Center Director and, earlier, as a Clinical Team Leader in CDERs Office of New Drugs, Division of Psychiatry, where he led multidisciplinary review teams and contributed to regulatory science and policy development in psychiatric drug development
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
Compare that to stopping prescription GLP-1 medication, where weight regain is well-documented
A California-based physician was the first to recognize the combined weight loss potential of phentermine and topiramate
GHK-Cus activation of DNA damage response networks (including ATM, BRCA1, and p53 pathways) in gene expression analyses positions it as a potential research subject for neurodegeneration prevention
Accessed 12/3/20, Lexicomp